U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090900
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 8MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued None No No
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 16MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued None No No
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 24MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/24/2011 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/25/2019 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

04/28/2016 SUPPL-6 Labeling-Package Insert

Label is not available on this site.

11/09/2015 SUPPL-5 Labeling-Package Insert

Label is not available on this site.

11/09/2015 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

Back to Top